PHARMA MAR, S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.96 EUR | +0.49% |
|
+10.37% | -29.50% |
| 04-23 | Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-29 | Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024 |
Evolution of the average Target Price on Pharma Mar, S.A.
Price target over the last 5 years
History of analyst recommendation changes
4138.g2swDDtexr0YALlwQYJEBIkd-VLxcI_pw_Fism8yb7o.sVJXRnUN9-9rNYESNsUhR-hHvD_BRPWelLsM5BpENYjsLEhKTnP3831G9A~2fbf4967677bf44c8e2933964c8e2a76
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
28.96
EUR
Average target price
49.2
EUR
Spread / Average Target
+69.89%
High Price Target
70
EUR
Spread / Highest target
+141.71%
Low Price Target
30
EUR
Spread / Lowest Target
+3.59%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B+
EPS Revisions
- Stock Market
- Equities
- PHM Stock
- Consensus Pharma Mar, S.A.
